» Articles » PMID: 28317684

Comparison of the Performance and Safety of 2 Ophthalmic Viscosurgical Devices in Cataract Surgery

Overview
Specialty Ophthalmology
Date 2017 Mar 21
PMID 28317684
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To compare the clinical performance and safety of 2 ophthalmic viscosurgical devices (OVDs)-Twinvisc (OVD 1) and Duovisc (OVD 2)-in cataract surgery.

Setting: European multicenter study.

Design: Prospective randomized controlled study.

Methods: Patients with cataract had phacoemulsification and intraocular lens implantation in 1 eye. They were randomly assigned to receive OVD 1 or OVD 2. Preoperative and postoperative examinations over 3 months included mean intraocular pressure (IOP), incidence of IOP peaks (≥30 mm Hg and ≥24 mm Hg), endothelial cell count (ECC), corneal thickness, and intraocular inflammation. A subjective evaluation of the OVDs was performed.

Results: The study comprised 220 patients. The incidence of IOP peaks and the mean IOP were not statistically significantly different between the 2 groups at any of the follow-up visits. At 6 hours, the incidence of IOP spikes 30 mm Hg or higher was 6.5% and 7.2% in the OVD 1 and the OVD 2 groups, respectively (P = .846). For the IOP spikes 24 mm Hg or higher, the incidence was 16.8% and 25.2%, respectively (P = .128). Three months postoperatively there was no statistically significant difference in ECC and pachymetry between the 2 groups. Mild inflammation was noticed up to 7 days postoperatively after which it resolved in both groups. Subjectively, the OVD 2 was easier to use, whereas the OVD 1 had better cohesive and dispersive properties.

Conclusions: Both OVDs have similar performance and safety profiles in phacoemulsification cataract surgery. No clinically relevant differences were found between the 2 devices regarding transient IOP spikes, mean IOP, corneal endothelium injury, or inflammation.

Citing Articles

Intraocular endothelial Keratogel Device for protection corneal endothelium during phacoemulsification cataract surgery.

Deshmukh R, Vajpayee R Eye (Lond). 2024; 39(4):622-623.

PMID: 39616280 PMC: 11885534. DOI: 10.1038/s41433-024-03518-y.


Optimal Timing for Intraocular Pressure Measurement Following Phacoemulsification Cataract Surgery: A Systematic Review and a Meta-Analysis.

Herspiegel W, Yu B, Algodi H, Malvankar-Mehta M, Hutnik C Vision (Basel). 2024; 8(4).

PMID: 39585115 PMC: 11587468. DOI: 10.3390/vision8040065.


Corneal endothelial cell loss and intraocular pressure following phacoemulsification using a new viscous-cohesive ophthalmic viscosurgical device.

Wood K, Pessach Y, Kovalyuk N, Lifshitz M, Winter H, Pikkel J Int Ophthalmol. 2024; 44(1):10.

PMID: 38319386 DOI: 10.1007/s10792-024-02997-y.


Corneal Outcomes Following Cataract Surgery Using Ophthalmic Viscosurgical Devices Composed of Chondroitin Sulfate-Hyaluronic Acid: A Systematic Review and Meta-Analysis.

Hsiao C, Cheng H, Ghafouri R, Ferko N, Ayres B Clin Ophthalmol. 2023; 17:2083-2096.

PMID: 37521151 PMC: 10378560. DOI: 10.2147/OPTH.S419863.


Evaluation of the Rheological Properties, Preclinical Safety, and Clinical Effectiveness of a New Dispersive Ophthalmic Viscoelastic Device for Cataract Surgery.

Palacio-Pastrana C, Munoz-Villegas P, Daniel-Dorantes F, Sanchez-Rios A, Olvera-Montano O, Martinez-Montoya Y Med Devices (Auckl). 2022; 15:293-305.

PMID: 36046598 PMC: 9421612. DOI: 10.2147/MDER.S379050.